ABSTRACT
OBJECTIVE: Although colorectal cancer screening (CRCS) is a public health priority, uptake is suboptimal in under-resourced groups. Noninvasive modalities, including stool deoxyribonucleic acid (sDNA) testing, may mitigate economic, geographic, cultural, or impairment-related barriers to CRCS. We assessed use of sDNA testing and other CRCS modalities in U.S. residents, comparing subgroups defined by several social determinants of health (SDOH). METHODS: A nationally representative sample of community-dwelling respondents aged 50-75 years self-reported use of CRCS modalities in the 2020 Behavioral Risk Factor Surveillance System Survey. Statistical analyses assessed up-to-date screening status and choice of modality in the recommended screening interval. RESULTS: Of 179,833 sampled respondents, 60.8% reported colonoscopy, 5.7% sDNA testing, 5.5% another modality. The rate of up-to-date screening was 72.0% overall and negatively associated with Hispanic ethnicity (63.6%), lower educational and annual income levels (e.g., Subject(s)
Colorectal Neoplasms
, Early Detection of Cancer
, Feces
, Humans
, Male
, Middle Aged
, Female
, Aged
, United States
, Feces/chemistry
, Colorectal Neoplasms/diagnosis
, Early Detection of Cancer/statistics & numerical data
, Behavioral Risk Factor Surveillance System
, DNA/analysis
, Colonoscopy/statistics & numerical data
, Mass Screening/statistics & numerical data
, Social Determinants of Health